![image2](https://www.med.unc.edu/microimm/wp-content/uploads/sites/745/2018/06/de-silva-lab-selected-for-eus-horizon-2020-zika-initiative-image2.jpeg)
The UNC School of Medicine was one of two U.S. institutions named to an international research consortium funded through the European Union’s Horizon 2020 Programme, which invested $49 million in Zika research and vaccine development at more than 20 laboratories in Europe and Brazil.